Nanomedicine News

RSS

Chemists Use DNA Molecules to Design Rapid, Inexpensive Medical Diagnostic Tests

Chemists at the University of Montreal used DNA molecules to developed rapid, inexpensive medical diagnostic tests that take only a few minutes to perform. Their findings, which will officially be published tomorrow in the Journal of the American Chemical Society, may aid efforts to build point-of-care devices for quick medical diagnosis of various diseases ranging from cancer, allergies, autoimmune diseases, sexually transmitted diseases (STDs), and many others.

23 Sep 2015

Scientists to Develop Smart Nanosensor Device for Diabetic Patients

A multidisciplinary team of researchers at Indiana University-Purdue University Indianapolis has been awarded a $738,000 National Science Foundation grant to develop a breathalyzer-type device to detect the onset of hypoglycemia, or low blood sugar episodes, in people with diabetes.

23 Sep 2015

Visiongain's Report Explains Potential of Nanomedicine to Redefine Nanopharmaceutical Market

Nanopharma - Discover Revenue Prospects Now, Benefiting Your Authority
Do you want to find sales potentials of nanomedicine? If so, our new analysis gives you revenue forecasts to 2025 at overall world market, application, product and national level. That way you discover financial data, trends, R&D, opportunities and commercial outlooks.

23 Sep 2015

Researchers Develop Stretchable, Transparent Conductor with Gold Nanomesh

Researchers have discovered a new stretchable, transparent conductor that can be folded or stretched and released, resulting in a large curvature or a significant strain, at least 10,000 times without showing signs of fatigue.

23 Sep 2015

CeloNova Receives FDA Approval for Nano-Coated COBRA PzF Coronary Stent IDE Trial

CeloNova BioSciences, Inc. (CeloNova) announced today that it has received conditional approval to start an investigational device exemption (IDE) trial to study the COBRA PzF coronary stent system in patients at high risk of bleeding. This is a second major interventional cardiology trial for CeloNova in the U.S., following the successful enrollment of the PzF SHIELD clinical trial earlier this year.

22 Sep 2015

leon-nanodrugs Expands Pharmaceutical Cooperation with Establishment of U.S. Operations

leon-nanodrugs GmbH today announced the appointment of industry veteran Theron (Ted) Odlaug, Ph.D. as the CEO for the leon-nanodrugs GmbH in Munich, Germany, and of its newly formed U.S. subsidiary leon-nanodrugs Inc., with offices in New York City and Chicago, Illinois. Recently, leon-nanodrugs successfully completed a Series A Financing round and announced using the proceeds to expand its profitable service business and to enter into high margin service and co-development deals with pharmaceutical partners.

22 Sep 2015

Matinas BioPharma Presents Data on MAT2203 Lipid-Crystal Nano-Particle Cochleate Technology at ICAAC/ICC 2015

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company focused on identifying and developing safe and effective antifungal and anti-bacterial therapeutics for the treatment of serious and life-threatening infections, today presented data from a preclinical study demonstrating tissue targeting and penetration potential of MAT2203, an orally-administered, encochleated formulation of the broad spectrum antifungal medication amphotericin B (AmB).

21 Sep 2015

Nanopore MinION Device Enables Rapid DNA Sequencing for Treatment of Urinary Tract Infections

Urinary tract infections (UTIs) could be treated more quickly and efficiently using a DNA sequencing device the size of a USB stick - according to research from the University of East Anglia.

21 Sep 2015

Ignyta Initiates RXDX-107 Phase 1/1b Clinical Trial of Alkyl Ester of Bendamustine Encapsulated in HSA to Form Nanoparticles

Ignyta, Inc., a precision oncology biotechnology company, announced today the initiation of the company’s Phase 1/1b clinical trial of RXDX-107, its next generation alkyl ester of bendamustine encapsulated in human serum albumin (HSA) to form nanoparticles.

21 Sep 2015

Injecting Gold Nanoparticles in Mammary Tissue Enhances Imaging of Early Signs of Breast Cancer

Detecting breast cancer in women with dense mammary tissues could become more reliable with a new mammogram procedure that researchers have now tested in pre-clinical studies of mice. In their report in the journal ACS Nano, they describe injecting gold nanoparticles in mammary tissue to enhance the imaging of early signs of breast cancer.

From American Chemical Society 18 Sep 2015

Nanomedicine News

Chemists Use DNA Molecules to Design Rapid, Inexpensive Medical Diagnostic Tests

Scientists to Develop Smart Nanosensor Device for Diabetic Patients

Visiongain's Report Explains Potential of Nanomedicine to Redefine Nanopharmaceutical Market

Researchers Develop Stretchable, Transparent Conductor with Gold Nanomesh

CeloNova Receives FDA Approval for Nano-Coated COBRA PzF Coronary Stent IDE Trial

leon-nanodrugs Expands Pharmaceutical Cooperation with Establishment of U.S. Operations

Matinas BioPharma Presents Data on MAT2203 Lipid-Crystal Nano-Particle Cochleate Technology at ICAAC/ICC 2015

Nanopore MinION Device Enables Rapid DNA Sequencing for Treatment of Urinary Tract Infections

Ignyta Initiates RXDX-107 Phase 1/1b Clinical Trial of Alkyl Ester of Bendamustine Encapsulated in HSA to Form Nanoparticles

Injecting Gold Nanoparticles in Mammary Tissue Enhances Imaging of Early Signs of Breast Cancer

Combining Nanofluids and Turbulators for Sustainable Energy

Enhancing Material Properties through Nanotube Encapsulation

Brain-Inspired Nano-Tech Promises New Era for Electronics

Breakthrough in 2D Material Growth Opens Doors to Cleaner Energy and Next-Generation Technology

Nanopore-Based Sensor Enables Rapid and Precise Disease Diagnosis

Conversations on AFM: Applications of BioAFM in Life Science

Conversations on AFM: The Technology and History Behind AFM and SPM

Recent Advances in High-Speed Atomic Force Microscopy to Improve Research Into Protein Dynamics

Sponsored Content

Characterization of Active Pharmaceutical Ingredients, Injectables, and Proteins

The Future of Wound Care: Why Nanofibers are Key to Accelerated Healing

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials